Deletion of the adenosine receptor A2A in myeloid cells has been shown to prevent tumor progression and metastasis in melanoma tumor models (282), as well as its inhibition, enhances CD8+ T cells response in head and neck squamous cell carcinoma (283). The gene discussed is CD8A; the disease is neoplasm.